H2-Dd Antibodies

Santa Cruz Biotechnology provides a broad selection of H2-Dd monoclonal antibodies for a variety of research applications. H2-Dd monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). H2-Dd is a major histocompatibility complex (MHC) class I molecule that plays a crucial role in the immune response by presenting peptide antigens to CD8+ T cells. Its function is vital for the recognition of infected or malignant cells, making H2-Dd an important target for studies related to immunology and cancer research. Understanding the interactions and mechanisms involving H2-Dd can provide insights into immune regulation and potential therapeutic strategies. H2-Dd monoclonal antibodies enable researchers to explore antigen presentation pathways and cellular immune responses. H2-Dd monoclonal antibodies support investigations into transplantation biology and autoimmune disorders. H2-Dd monoclonal antibodies facilitate research in tumor immunology and vaccine development. Santa Cruz Biotechnology monoclonal antibodies empower researchers worldwide to advance scientific understanding of immune system dynamics and disease mechanisms.